InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-9.7%
Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Perry Nicole D, Chief Executive Officer. Insider active across 2 companies, notably Apellis Pharmaceuticals, Inc.. In total, 12 reports have been recorded. Activity tracked since 30 April 2021. The latest transaction was disclosed on 2 August 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations12 total
1,000 shares@ US$3.760.0001% mcap8.7% of flowCommon StockSEC:0001127602-21-022938:0
1,000 shares@ US$3.768.7% of flowCommon StockSEC:0001127602-21-022938
1,000 shares@ US$3.768.7% of flowCommon StockSEC:0001127602-21-021194
1,000 shares@ US$3.760.0001% mcap8.7% of flowCommon StockSEC:0001127602-21-021194:0
1,000 shares@ US$3.207.2% of flowCommon StockSEC:0001127602-21-019902
1,000 shares@ US$3.200.0001% mcap7.2% of flowCommon StockSEC:0001127602-21-019902:0
1,000 shares@ US$3.768.4% of flowCommon StockSEC:0001127602-21-018704
1,000 shares@ US$3.760.0001% mcap8.4% of flowCommon StockSEC:0001127602-21-018704:0
1,000 shares@ US$3.760.0001% mcap8.5% of flowCommon StockSEC:0001127602-21-015186:0
1,000 shares@ US$3.768.5% of flowCommon StockSEC:0001127602-21-015186
1,000 shares@ US$3.760.0001% mcap8.5% of flowCommon StockSEC:0001127602-21-014986:0
1,000 shares@ US$3.768.5% of flowCommon StockSEC:0001127602-21-014986
12 of 12 declarations
About Perry Nicole D
Nicole D. Perry is the Chief Executive Officer and Vice President - Accounting at Apellis Pharmaceuticals, Inc. She is responsible for the strategic and operational leadership of the company. Her expertise in accounting and business management is essential to support the company's growth and performance.
